Agilent Technologies Inc.

Agilent Technologies, Inc., commonly known as Agilent, is an American global company headquartered in Santa Clara, California, founded in 1999 as a spin-off from Hewlett-Packard. It is a publicly traded company on the New York Stock Exchange under the ticker symbol "A". As of fiscal year 2025, Agilent reported revenues of $6.95 billion and employed approximately 18,100 people worldwide, with a market capitalization of around $36.7 billion as of June 2026.

Agilent is a leader in life sciences, diagnostics, and applied markets, providing instruments, software, services, and consumables for laboratories globally. Its comprehensive portfolio includes solutions for automation, bioreagents, gas and liquid chromatography, mass spectrometry, spectroscopy, microarrays, and vacuum technologies. The company serves various markets, including pharmaceutical, diagnostics & clinical, academic & government research, environmental testing, food safety, and petrochemicals.

In terms of patent litigation, Agilent Technologies, Inc. is an active two-way litigant, engaged in direct intellectual property disputes. The company has appeared as a plaintiff in two tracked cases and as a defendant in two tracked cases. All of these cases involve Synthego Corp., indicating a specific dispute between the two entities rather than broad patent assertion or defense against non-practicing entities.

All four of Agilent's tracked cases involve Synthego Corp., with proceedings occurring in the U.S. Court of Appeals for the Federal Circuit (CAFC) and the U.S. Patent Trial and Appeal Board (PTAB). These cases include Agilent Technologies, Inc. v. Synthego Corp. (plaintiff) and Synthego Corporation v. Agilent Technologies, Inc. (defendant), reflecting a concurrent legal battle over patent rights between the two companies.